The Latest Cardiac and Vascular News
– Abbott’s Talisman system seals an opening in the heart known as a “patent foramen ovale” (PFO) to prevent blood clots from passing from the right to the left side of the heart and on to the brain, where they can cause a stroke – The Talisman system builds on […]
New data from the MOMENTUM 3 study showed for the first time that a heart pump can extend survival to five years and beyond for advanced heart failure patients Prior data1 have shown survival for advanced heart failure patients who don’t receive either a heart pump or heart transplant is […]
McDermott + Bull Partner Ken Dropiewski talks with CRG Director Sabir Rassiwalla about what drove him to CRG after a long tenure with Abbott.
Sales growth of 10.1 percent; organic sales growth of 14.3 percent GAAP diluted EPS growth of 72.7 percent; adjusted diluted EPS growth of 22.2 percent Global COVID-19 testing-related sales of $2.3 billion in the second quarter Continues to strengthen portfolio with new product approvals ABBOTT PARK, Ill., July 20, 2022 /PRNewswire/ — Abbott (NYSE: ABT) […]
– New results demonstrate MitraClip™ transcatheter edge-to-edge repair (TEER) is effective at treating leaky valves in people with secondary mitral regurgitation (MR) – Data from the first report on patients with a pacemaker lead across the tricuspid valve show TriClip™ and TriClip G4 TEER systems significantly reduce tricuspid regurgitation (TR) […]
Data presented at EuroPCR 2022 reinforce the impact of Abbott’s minimally invasive heart devices on patient outcomes and quality of life Findings demonstrate TriClip™ transcatheter edge-to-edge (TEER) repair is effective at reducing tricuspid regurgitation across a broad range of anatomies One-year outcomes for Navitor™ transcatheter aortic valve implantation (TAVI) system […]
Treatment with the TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™ resulted in patients with persistent atrial fibrillation experiencing an improved quality of life The catheter is part of Abbott’s suite of electrophysiology solutions designed to improve procedures to address cardiac arrythmias ABBOTT PARK, Ill., April 29, 2022 /PRNewswire/ — Abbott (NYSE: ABT) today […]
First and only steerable delivery system designed to help seal the left atrial appendage (LAA) in people with atrial fibrillation who are at an increased risk of stroke Now available in the U.S., Abbott’s steerable sheath offers precise and flexible placement when used with the company’s Amplatzer Amulet LAA Occluder […]
Sales growth of 13.8 percent; organic sales growth of 17.5 percent Global COVID-19 testing-related sales of $3.3 billion in the first quarter Excluding COVID-19 testing-related sales, first-quarter reported sales growth of 3.9 percent and organic sales growth of 7.7 percent GAAP diluted EPS growth of 37.0 percent; adjusted diluted EPS growth of […]
Abbott’s Aveir single chamber (VR) pacing system is the world’s only leadless pacemaker with a unique mapping capability to assess correct positioning prior to placement Aveir VR has an increased projected battery life that can be up to two times longer than other commercially available leadless pacemakers when using the […]
